[ad_1]
New York, January 11, 2022 /PRNewswire/——
Why: Rosen LLP, a global investor rights law firm, reminds buyers to buy Reata Pharmaceuticals, Inc. (NASDAQ:straight) between November 9, 2020 and December 8, 2021, including (“during class”), significant February 18, 2022 lead plaintiff deadline.
So: If you purchased Reata Pharmaceuticals securities during a class action, you may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs or costs.
What to do next: To join the Reata Pharmaceuticals class action, visit http://www.rosenlegal.com/cases-register-2230.html or call Philip King, Esq. Toll Free 866-767-3653 or email pkim@rosenlegal.com or case@rosenlegal.com Information about the course…
The full story is available on Benzinga.com
[ad_2]
Source link
